Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug eruptions induced by allopurinol associated with HLA-B*5801.

Indian journal of dermatology, venereology and leprology - 1 Jan 2000

Zeng Meihua, Zhang Min, Liu Fang, Yan Wenliang, Kong Qingtao, Sang Hong

Abstract excerpt

Allopurinol, a drug commonly used for treating gout and hyperuricemia, is a frequent cause of drug eruptions. Recent investigations suggest that HLA-BFNx015801 allele is a very strong marker for allopurinol-induced cutaneous adverse drug reactions (cADRs). In this article we report two cases of allopurinol-induced drug eruptions in patients carrying the HLA-BFNx015801 allele and review the literature on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alleles
Share to Allopurinol

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Eruptions

Share to Gout Suppressants

Share to HLA-B Antigens

Source

Identifiers

PMID: 25566896
DOI: 10.4103/0378-6323.148566

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug eruptions induced by allopurinol associated with HLA-B*5801.PMID 25566896Read ↗

HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese.Semantic proximity Read ↗

Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review.Semantic proximity Read ↗

Impact of the HLA-B(*)58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions.Semantic proximity Read ↗

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.Semantic proximity Read ↗

Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.Semantic proximity Read ↗

Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions.Semantic proximity Read ↗

Allopurinol-induced DRESS in a Han Chinese patient with HLA-B*58:01.Semantic proximity Read ↗

Dose dependent Drug Reaction with Eosinophilia and Systemic Symptoms to allopurinol in a Caucasian femaleSemantic proximity Read ↗

HLA alleles and drug hypersensitivity reactions.Semantic proximity Read ↗

HLA-DR9 and DR14 are associated with the allopurinol-induced hypersensitivity in hematologic malignancy.Semantic proximity Read ↗

HLA-B*58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in ThailandSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.